Table 4.

Estimated risk of 3-year balance performance decline (95% CI).

	N	Number of Events	Incidence (% Participant/y)	95% CI	RR *	95% CI	Raw p Value	Adjusted p Value
ω3-PUFA	420	119	14.63	12.00–17.26	1.03	0.79–1.35	0.834	0.834
ω3-PUFA + Multidomain Intervention	416	122	14.76	12.14–17.38	1.05	0.80–1.37	0.736	0.834
Multidomain Intervention + Placebo	419	116	13.74	11.24–16.24	0.95	0.73–1.25	0.720	0.834
Placebo	419	120	14.02	11.51–16.53	1	-	-	-

* Interaction group time; p = 0.4327.